Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
solid tumor
Biotech
CatalYm C-suite shake-up sees 4 new faces, 3 departures
CatalYm has tapped four industry leaders to join the immunotherapy biotech, a move that has prompted three other executives to hit the exit.
Gabrielle Masson
Sep 15, 2025 10:53am
PMV plots ovarian cancer filing after seeing midphase data
Sep 10, 2025 9:40am
VantAI plays matchmaker for Halda's RIPTACs in $1B deal
Aug 19, 2025 8:00am
Big Pharmas back Strand's $153M series B to advance mRNA drugs
Aug 7, 2025 9:20am
Cell therapy biotech keeps adapting, selling 4 programs for $55M
Jul 28, 2025 10:52am
Roche axes Carmot obesity asset, 3 cancer drugs in R&D clear-out
Jul 24, 2025 5:00am
